CNR1 and inflammatory bowel disease: Another molecule of interest in IBD is palmitoylethanolamide (PEA), a structural relative of anandamide that acts via multiple targets including CB1, CB2, GPR55, PPARα, and TRPV1 and that has been reported to reduce inflammation and intestinal permeability in mice [26–28].